Bekris LM - Search Results

1

AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.

Zhou Y, Fang J, Bekris LM, Kim YH, Pieper AA, Leverenz JB, Cummings J, Cheng F. Zhou Y, et al. Among authors: bekris lm. Alzheimers Res Ther. 2021 Jan 13;13(1):24. doi: 10.1186/s13195-020-00760-w. Alzheimers Res Ther. 2021. PMID: 33441136 Free PMC article.

2

Harnessing endophenotypes and network medicine for Alzheimer's drug repurposing.

Fang J, Pieper AA, Nussinov R, Lee G, Bekris L, Leverenz JB, Cummings J, Cheng F. Fang J, et al. Med Res Rev. 2020 Nov;40(6):2386-2426. doi: 10.1002/med.21709. Epub 2020 Jul 13. Med Res Rev. 2020. PMID: 32656864 Free PMC article. Review.

3

The Alzheimer's Cell Atlas (TACA): A single-cell molecular map for translational therapeutics accelerator in Alzheimer's disease.

Zhou Y, Xu J, Hou Y, Bekris L, Leverenz JB, Pieper AA, Cummings J, Cheng F. Zhou Y, et al. Alzheimers Dement (N Y). 2022 Oct 13;8(1):e12350. doi: 10.1002/trc2.12350. eCollection 2022. Alzheimers Dement (N Y). 2022. PMID: 36254161 Free PMC article.

4

The biomarker and therapeutic potential of miRNA in Alzheimer's disease.

Bekris LM, Leverenz JB. Bekris LM, et al. Neurodegener Dis Manag. 2015;5(1):61-74. doi: 10.2217/nmt.14.52. Neurodegener Dis Manag. 2015. PMID: 25711455 Review.

5

Multimodal single-cell/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer's disease.

Xu J, Zhang P, Huang Y, Zhou Y, Hou Y, Bekris LM, Lathia J, Chiang CW, Li L, Pieper AA, Leverenz JB, Cummings J, Cheng F. Xu J, et al. Among authors: bekris lm. Genome Res. 2021 Oct;31(10):1900-1912. doi: 10.1101/gr.272484.120. Epub 2021 Feb 24. Genome Res. 2021. PMID: 33627474 Free PMC article.

6

Regulation of ADAM10 by miR-140-5p and potential relevance for Alzheimer's disease.

Akhter R, Shao Y, Shaw M, Formica S, Khrestian M, Leverenz JB, Bekris LM. Akhter R, et al. Among authors: bekris lm. Neurobiol Aging. 2018 Mar;63:110-119. doi: 10.1016/j.neurobiolaging.2017.11.007. Epub 2017 Nov 23. Neurobiol Aging. 2018. PMID: 29253717 Free PMC article.

7

Highly Elevated Cerebrospinal Fluid Total Tau Level Reflects Higher Likelihood of Non-Amnestic Subtype of Alzheimer's Disease.

Pillai JA, Bonner-Jackson A, Bekris LM, Safar J, Bena J, Leverenz JB. Pillai JA, et al. Among authors: bekris lm. J Alzheimers Dis. 2019;70(4):1051-1058. doi: 10.3233/JAD-190519. J Alzheimers Dis. 2019. PMID: 31306137 Free PMC article.

8

Emerging blood-based biomarkers for Alzheimer disease.

Bekris LM, Leverenz JB. Bekris LM, et al. Cleve Clin J Med. 2020 Aug 31;87(9):537-539. doi: 10.3949/ccjm.87a.20133. Cleve Clin J Med. 2020. PMID: 32868302 Free article. No abstract available.

9

Unique Sleep and Circadian Rhythm Dysfunction Neuroinflammatory and Immune Profiles in Alzheimer's Disease with Mild Cognitive Impairment.

Pillai JA, Bena J, Bekris LM, Foldvary-Schaefer N, Heinzinger C, Rao S, Rao SM, Leverenz JB, Mehra R. Pillai JA, et al. Among authors: bekris lm. J Alzheimers Dis. 2021;81(2):487-492. doi: 10.3233/JAD-201573. J Alzheimers Dis. 2021. PMID: 33814445 Free PMC article.

10

Peripheral sTREM2-Related Inflammatory Activity Alterations in Early-Stage Alzheimer's Disease.

Weber GE, Khrestian M, Tuason ED, Shao Y, Pillai J, Rao S, Feng H, Zhou Y, Cheng F, DeSilva TM, Stauffer S, Leverenz JB, Bekris LM. Weber GE, et al. Among authors: bekris lm. J Immunol. 2022 May 15;208(10):2283-2299. doi: 10.4049/jimmunol.2100771. Epub 2022 May 6. J Immunol. 2022. PMID: 35523454 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters